Chardan Capital Issues Pessimistic Forecast for Iovance Biotherapeutics (NASDAQ:IOVA) Stock Price
Iovance Biotherapeutics (NASDAQ:IOVA – Get Free Report) had its target price decreased by equities researchers at Chardan Capital from $34.00 to $30.00 in a note issued to investors on Monday,Benzinga reports. The brokerage presently has a “buy” rating on the biotechnology company’s stock. IOVA has been the topic of several other research reports. Piper Sandler […]
Iovance Biotherapeutics (NASDAQ:IOVA – Get Free Report) had its target price decreased by equities researchers at Chardan Capital from $34.00 to $30.00 in a note issued to investors on Monday,Benzinga reports. The brokerage presently has a “buy” rating on the biotechnology company’s stock. IOVA has been the topic of several other research reports. Piper Sandler […]
